NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 13 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,225,645 | +1.1% | 6,667,000 | 0.0% | 0.03% | -6.7% |
| Q2 2023 | $6,160,308 | -1.7% | 6,667,000 | 0.0% | 0.03% | -6.2% |
| Q1 2023 | $6,266,980 | +20.5% | 6,667,000 | +17.6% | 0.03% | -15.8% |
| Q4 2022 | $5,199,473 | -3.1% | 5,667,000 | 0.0% | 0.04% | +18.8% |
| Q3 2022 | $5,364,000 | +1.6% | 5,667,000 | 0.0% | 0.03% | +23.1% |
| Q2 2022 | $5,281,000 | -83.8% | 5,667,000 | -81.2% | 0.03% | -71.1% |
| Q1 2022 | $32,611,000 | -8.2% | 30,167,000 | -5.5% | 0.09% | +52.5% |
| Q4 2021 | $35,522,000 | -17.6% | 31,917,000 | 0.0% | 0.06% | -30.6% |
| Q3 2021 | $43,108,000 | +13.5% | 31,917,000 | +45.6% | 0.08% | -1.2% |
| Q2 2021 | $37,971,000 | +149.9% | 21,917,000 | +119.2% | 0.09% | +91.1% |
| Q1 2021 | $15,196,000 | – | 10,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 10,000,000 | $15,644,000 | 3.40% |
| Perceptive Advisors | 9,000,000 | $141,822,000 | 2.07% |
| DeepCurrents Investment Group LLC | 14,430,000 | $22,483,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,784,000 | 0.46% |
| Polar Asset Management Partners Inc. | 17,500,000 | $27,302,000 | 0.37% |
| ZAZOVE ASSOCIATES LLC | 1,320,000 | $2,063,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,000,000 | $24,947,000 | 0.22% |
| Context Capital Management, LLC | 500,000 | $768,000 | 0.17% |
| Context Partners Fund, L.P. | 500,000 | $768,000 | 0.17% |
| PFM Health Sciences, LP | 2,000,000 | $3,151,000 | 0.15% |